Premium
Tumor characterization with dynamic contrast–enhanced MRI using mr contrast agents of various molecular weights
Author(s) -
Su MinYing,
Mühler Andreas,
Lao Xiaoyan,
Nalcioglu Orhan
Publication year - 1998
Publication title -
magnetic resonance in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.696
H-Index - 225
eISSN - 1522-2594
pISSN - 0740-3194
DOI - 10.1002/mrm.1910390213
Subject(s) - vascular permeability , permeability (electromagnetism) , polylysine , interstitial space , kinetics , chemistry , biophysics , nuclear magnetic resonance , pathology , nuclear medicine , medicine , biology , biochemistry , physics , quantum mechanics , membrane
Dynamic contrast‐enhanced MR imaging was used to measure the kinetics of enhancement in three different animal tumor models (Walker 256, R3230 AC, MCF7) using three different Gd complexes (Gd‐DTPA, Gd‐DTPA‐24‐cascade‐poly‐mer 30 kD, and polylysine‐Gd‐DTPA 50 kD). The three tumor models varied in growth rate, with the most rapid growth demonstrated by Walker 256 cells and the slowest growth occurring in the MCF7 cells. For each tumor, the kinetics of enhancement using polylysine‐Gd‐DTPA was analyzed using a pharmacokinetic model to estimate the vascular volume of the tumor. The rate of entry of the contrast agent into the interstitial space served as the measure of vascular permeability. The smallest molecular‐weight agent, Gd‐DTPA, could not provide information about vascular permeability. The intermediate and the largest agents both demonstrated that the faster‐growing Walker 256 tumor had greater vascular permeability than did the slower‐growing R3230 AC tumor. The degree of vascular permeability in the MCF7 tumor could not be assessed fairly due to insufficient statistics. The current study provides evidence supporting the hypothesis that more rapidly growing tumors have higher vascular permeability than do tumors that grow more slowly.